We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Computer System Launched To Manage Blood Screening Data

By LabMedica International staff writers
Posted on 21 Oct 2008
Print article
A computer system was launched that improves laboratory efficiency by managing test data when screening donated blood for hepatitis and retroviruses.

The new system will enable laboratories to track and trend quality control and performance of blood-screening assays and will provide laboratories with robust data capabilities through expanded archival features. It also will help blood-screening laboratories manage retesting of samples, produce reports, and generate statistical charts.

Called the Abbott Prism Director, the new system was launched by Abbott (Abbott Park, IL, USA) at the American Association of Blood Banks annual meeting on October 7, 2008, in Montreal, Canada. The Abbott Prism is an automated immunoassay analyzer designed to perform in vitro diagnostic donor screening for hepatitis and retroviruses. The analyzer is used by blood, plasma, organ, and tissue centers in more than 30 countries to screen more than 40 million donations each year.

"The worldwide launch of the Abbott Prism Director brings an important new product to our expanding portfolio of blood-screening systems and assays and demonstrates our continued commitment to blood-screening laboratories and the overall safety of the blood supply,” said James Stewart, Ph.D., director of research and development, Abbott Diagnostics. "For testing facilities that use multiple or single Abbott Prism instruments, the Abbott Prism Director offers data management functionality that can significantly enhance laboratory operations.”

Abbott is a global leader in in vitro diagnostics and provides a broad range of instrument systems and tests for hospitals, reference labs, molecular labs, blood banks, physician offices, and clinics. The company's diagnostic products offer customers automation, convenience, bedside testing, cost effectiveness, and flexibility.

Related Links:
Abbott

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Biological Indicator Vials
BI-O.K.
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
25-OH-VD Reagent Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.